-
1
-
-
84872975055
-
MicroRNAs, stem cells and cancer stem cells
-
22993663
-
MicroRNAs, stem cells and cancer stem cells. Garg M, World J Stem Cells 2012 4 62 70 22993663
-
(2012)
World J Stem Cells
, vol.4
, pp. 62-70
-
-
Garg, M.1
-
2
-
-
41549110185
-
Control of protein synthesis and mRNA degradation by microRNAs
-
10.1016/j.ceb.2008.01.006 18329869
-
Control of protein synthesis and mRNA degradation by microRNAs. Liu J, Curr Opin Cell Biol 2008 20 214 221 10.1016/j.ceb.2008.01.006 18329869
-
(2008)
Curr Opin Cell Biol
, vol.20
, pp. 214-221
-
-
Liu, J.1
-
3
-
-
33644768174
-
Control of translation and mRNA degradation by miRNAs and siRNAs
-
DOI 10.1101/gad.1399806
-
Control of translation and mRNA degradation by miRNAs and siRNAs. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R, Genes Dev 2006 20 515 524 10.1101/gad.1399806 16510870 (Pubitemid 43345317)
-
(2006)
Genes and Development
, vol.20
, Issue.5
, pp. 515-524
-
-
Valencia-Sanchez, M.A.1
Liu, J.2
Hannon, G.J.3
Parker, R.4
-
4
-
-
66049133419
-
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells
-
10.1016/j.ceb.2009.04.009 19450959
-
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Chekulaeva M, Filipowicz W, Curr Opin Cell Biol 2009 21 452 460 10.1016/j.ceb.2009.04.009 19450959
-
(2009)
Curr Opin Cell Biol
, vol.21
, pp. 452-460
-
-
Chekulaeva, M.1
Filipowicz, W.2
-
5
-
-
58649087374
-
MiR-21: A small multi-faceted RNA
-
19175699
-
miR-21: a small multi-faceted RNA. Krichevsky AM, Gabriely G, J Cell Mol Med 2009 13 39 53 19175699
-
(2009)
J Cell Mol Med
, vol.13
, pp. 39-53
-
-
Krichevsky, A.M.1
Gabriely, G.2
-
6
-
-
33144490646
-
A microRNA expression signature of human solid tumors defines cancer gene targets
-
DOI 10.1073/pnas.0510565103
-
A microRNA expression signature of human solid tumors defines cancer gene targets. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM, Proc Natl Acad Sci U S A 2006 103 2257 2261 10.1073/pnas.0510565103 16461460 (Pubitemid 43271657)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.7
, pp. 2257-2261
-
-
Volinia, S.1
Calin, G.A.2
Liu, C.-G.3
Ambs, S.4
Cimmino, A.5
Petrocca, F.6
Visone, R.7
Iorio, M.8
Roldo, C.9
Ferracin, M.10
Prueitt, R.L.11
Yanaihara, N.12
Lanza, G.13
Scarpa, A.14
Vecchione, A.15
Negrini, M.16
Harris, C.C.17
Croce, C.M.18
-
7
-
-
70349309149
-
MiR-21 as a key regulator of oncogenic processes
-
10.1042/BST0370918 19614619
-
miR-21 as a key regulator of oncogenic processes. Selcuklu SD, Donoghue MT, Spillane C, Biochem Soc Trans 2009 37 918 925 10.1042/BST0370918 19614619
-
(2009)
Biochem Soc Trans
, vol.37
, pp. 918-925
-
-
Selcuklu, S.D.1
Donoghue, M.T.2
Spillane, C.3
-
8
-
-
84861686487
-
MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1alpha expression in third-sphere forming breast cancer stem cell-like cells
-
10.1111/j.1349-7006.2012.02281.x 22435731
-
MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1alpha expression in third-sphere forming breast cancer stem cell-like cells. Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N, Zhu Z, Mo Z, Wu C, Chen X, Cancer Sci 2012 103 1058 1064 10.1111/j.1349-7006.2012.02281.x 22435731
-
(2012)
Cancer Sci
, vol.103
, pp. 1058-1064
-
-
Han, M.1
Wang, Y.2
Liu, M.3
Bi, X.4
Bao, J.5
Zeng, N.6
Zhu, Z.7
Mo, Z.8
Wu, C.9
Chen, X.10
-
9
-
-
43449100341
-
REST maintains self-renewal and pluripotency of embryonic stem cells
-
DOI 10.1038/nature06863, PII NATURE06863
-
REST maintains self-renewal and pluripotency of embryonic stem cells. Singh SK, Kagalwala MN, Parker-Thornburg J, Adams H, Majumder S, Nature 2008 453 223 227 10.1038/nature06863 18362916 (Pubitemid 351667975)
-
(2008)
Nature
, vol.453
, Issue.7192
, pp. 223-227
-
-
Singh, S.K.1
Kagalwala, M.N.2
Parker-Thornburg, J.3
Adams, H.4
Majumder, S.5
-
10
-
-
72949111146
-
MicroRNA regulation of cancer stem cells and therapeutic implications
-
10.1208/s12248-009-9147-7 19842044
-
MicroRNA regulation of cancer stem cells and therapeutic implications. DeSano JT, Xu L, AAPS J 2009 11 682 692 10.1208/s12248-009-9147-7 19842044
-
(2009)
AAPS J
, vol.11
, pp. 682-692
-
-
Desano, J.T.1
Xu, L.2
-
11
-
-
58849163959
-
MicroRNAs: Key regulators of stem cells
-
10.1038/nrm2621 19165214
-
MicroRNAs: key regulators of stem cells. Gangaraju VK, Lin H, Nat Rev Mol Cell Biol 2009 10 116 125 10.1038/nrm2621 19165214
-
(2009)
Nat Rev Mol Cell Biol
, vol.10
, pp. 116-125
-
-
Gangaraju, V.K.1
Lin, H.2
-
12
-
-
80052857162
-
High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer
-
10.1111/j.1600-0463.2011.02782.x 21917003
-
High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. Rask L, Balslev E, Jorgensen S, Eriksen J, Flyger H, Moller S, Hogdall E, Litman T, Nielsen BS, APMIS 2011 119 663 673 10.1111/j.1600-0463.2011.02782.x 21917003
-
(2011)
APMIS
, vol.119
, pp. 663-673
-
-
Rask, L.1
Balslev, E.2
Jorgensen, S.3
Eriksen, J.4
Flyger, H.5
Moller, S.6
Hogdall, E.7
Litman, T.8
Nielsen, B.S.9
-
13
-
-
83555171758
-
Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth
-
10.1186/bcr2803 21219636
-
Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, Fu J, Zeng MS, Yun JP, Wu QL, Zeng YX, Shao JY, Breast Cancer Res 2011 13 2 10.1186/bcr2803 21219636
-
(2011)
Breast Cancer Res
, vol.13
, pp. 182
-
-
Yan, L.X.1
Wu, Q.N.2
Zhang, Y.3
Li, Y.Y.4
Liao, D.Z.5
Hou, J.H.6
Fu, J.7
Zeng, M.S.8
Yun, J.P.9
Wu, Q.L.10
Zeng, Y.X.11
Shao, J.Y.12
-
14
-
-
77950905590
-
MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression
-
10.1186/1756-9966-29-29 20346171
-
MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. Song B, Wang C, Liu J, Wang X, Lv L, Wei L, Xie L, Zheng Y, Song X, J Exp Clin Cancer Res 2010 29 29 10.1186/1756-9966-29-29 20346171
-
(2010)
J Exp Clin Cancer Res
, vol.29
, pp. 29
-
-
Song, B.1
Wang, C.2
Liu, J.3
Wang, X.4
Lv, L.5
Wei, L.6
Xie, L.7
Zheng, Y.8
Song, X.9
-
15
-
-
84861489369
-
MiR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells
-
21968270
-
miR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells. Lou Y, Cui Z, Wang F, Yang X, Qian J, Clin Invest Med 2011 34 281 21968270
-
(2011)
Clin Invest Med
, vol.34
, pp. 5281
-
-
Lou, Y.1
Cui, Z.2
Wang, F.3
Yang, X.4
Qian, J.5
-
16
-
-
78649919224
-
MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein
-
21042775
-
MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Lou Y, Yang X, Wang F, Cui Z, Huang Y, Int J Mol Med 2010 26 819 827 21042775
-
(2010)
Int J Mol Med
, vol.26
, pp. 819-827
-
-
Lou, Y.1
Yang, X.2
Wang, F.3
Cui, Z.4
Huang, Y.5
-
17
-
-
84857898266
-
Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells
-
10.1007/s11010-011-1195-5 22187223
-
Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells. Han M, Liu M, Wang Y, Mo Z, Bi X, Liu Z, Fan Y, Chen X, Wu C, Mol Cell Biochem 2012 363 427 436 10.1007/s11010-011-1195-5 22187223
-
(2012)
Mol Cell Biochem
, vol.363
, pp. 427-436
-
-
Han, M.1
Liu, M.2
Wang, Y.3
Mo, Z.4
Bi, X.5
Liu, Z.6
Fan, Y.7
Chen, X.8
Wu, C.9
-
18
-
-
84862638243
-
Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN
-
10.1371/journal.pone.0039520 22761812
-
Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y, Wu C, PLoS One 2012 7 39520 10.1371/journal.pone.0039520 22761812
-
(2012)
PLoS One
, vol.7
, pp. 539520
-
-
Han, M.1
Liu, M.2
Wang, Y.3
Chen, X.4
Xu, J.5
Sun, Y.6
Zhao, L.7
Qu, H.8
Fan, Y.9
Wu, C.10
-
19
-
-
49249091523
-
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
-
10.1158/0008-5472.CAN-08-0364 18519691
-
Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP, Cancer Res 2008 68 4311 4320 10.1158/0008-5472.CAN-08-0364 18519691
-
(2008)
Cancer Res
, vol.68
, pp. 4311-4320
-
-
Zhang, S.1
Balch, C.2
Chan, M.W.3
Lai, H.C.4
Matei, D.5
Schilder, J.M.6
Yan, P.S.7
Huang, T.H.8
Nephew, K.P.9
-
20
-
-
58149502524
-
Comparison of clinical presentation of benign and malignant ovarian tumours
-
19213371
-
Comparison of clinical presentation of benign and malignant ovarian tumours. Wasim T, Majrroh A, Siddiq S, J Pak Med Assoc 2009 59 18 21 19213371
-
(2009)
J Pak Med Assoc
, vol.59
, pp. 18-21
-
-
Wasim, T.1
Majrroh, A.2
Siddiq, S.3
-
21
-
-
4344714263
-
Evidence of parthenogenetic origin of ovarian teratoma: Case report
-
DOI 10.1093/humrep/deh345
-
Evidence of parthenogenetic origin of ovarian teratoma: case report. Oliveira FG, Dozortsev D, Diamond MP, Fracasso A, Abdelmassih S, Abdelmassih V, Goncalves SP, Abdelmassih R, Nagy ZP, Hum Reprod 2004 19 1867 1870 10.1093/humrep/deh345 15192066 (Pubitemid 39144637)
-
(2004)
Human Reproduction
, vol.19
, Issue.8
, pp. 1867-1870
-
-
Garcia Oliveira, F.1
Dozortsev, D.2
Diamond, M.P.3
Fracasso, A.4
Abdelmassih, S.5
Abdelmassih, V.6
Goncalves, S.P.7
Abdelmassih, R.8
Nagy, Z.P.9
-
22
-
-
84864669041
-
Management of giant ovarian teratoma: A case series and review of the literature
-
23205081
-
Management of giant ovarian teratoma: a case series and review of the literature. Ye LY, Wang JJ, Liu DR, Ding GP, Cao LP, Oncol Lett 2012 4 672 676 23205081
-
(2012)
Oncol Lett
, vol.4
, pp. 672-676
-
-
Ye, L.Y.1
Wang, J.J.2
Liu, D.R.3
Ding, G.P.4
Cao, L.P.5
-
23
-
-
79959297331
-
Mixed malignant germ cell tumor of ovary
-
10.2298/MPNS1102093S 21548277
-
[Mixed malignant germ cell tumor of ovary]. Sviracevic B, Sedlar S, Malobabic D, Cuk D, Med Pregl 2011 64 93 95 10.2298/MPNS1102093S 21548277
-
(2011)
Med Pregl
, vol.64
, pp. 93-95
-
-
Sviracevic, B.1
Sedlar, S.2
Malobabic, D.3
Cuk, D.4
-
24
-
-
78751703133
-
Malignant mixed ovarian germ cell tumor with embryonal component
-
10.1016/j.jpag.2010.05.001 20869284
-
Malignant mixed ovarian germ cell tumor with embryonal component. Moniaga NC, Randall LM, J Pediatr Adolesc Gynecol 2011 24 1 e3 10.1016/j.jpag.2010.05. 001 20869284
-
(2011)
J Pediatr Adolesc Gynecol
, vol.24
-
-
Moniaga, N.C.1
Randall, L.M.2
-
26
-
-
16844368698
-
Tumour stem cells and drug resistance
-
DOI 10.1038/nrc1590
-
Tumour stem cells and drug resistance. Dean M, Fojo T, Bates S, Nat Rev Cancer 2005 5 275 284 10.1038/nrc1590 15803154 (Pubitemid 40488633)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.4
, pp. 275-284
-
-
Dean, M.1
Fojo, T.2
Bates, S.3
-
27
-
-
79952403624
-
Technologies and methods used for the detection, enrichment and characterization of cancer stem cells
-
21561046
-
Technologies and methods used for the detection, enrichment and characterization of cancer stem cells. Williams A, Datar R, Cote R, Natl Med J India 2010 23 346 350 21561046
-
(2010)
Natl Med J India
, vol.23
, pp. 346-350
-
-
Williams, A.1
Datar, R.2
Cote, R.3
-
28
-
-
33746625091
-
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness
-
DOI 10.1073/pnas.0603672103
-
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK, Proc Natl Acad Sci U S A 2006 103 11154 11159 10.1073/pnas.0603672103 16849428 (Pubitemid 44156488)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.30
, pp. 11154-11159
-
-
Szotek, P.P.1
Pieretti-Vanmarcke, R.2
Masiakos, P.T.3
Dinulescu, D.M.4
Connolly, D.5
Foster, R.6
Dombkowski, D.7
Preffer, F.8
MacLaughlin, D.T.9
Donahoe, P.K.10
-
29
-
-
17144403478
-
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
-
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Bapat SA, Mali AM, Koppikar CB, Kurrey NK, Cancer Res 2005 65 3025 3029 15833827 (Pubitemid 40524578)
-
(2005)
Cancer Research
, vol.65
, Issue.8
, pp. 3025-3029
-
-
Bapat, S.A.1
Mali, A.M.2
Koppikar, C.B.3
Kurrey, N.K.4
-
30
-
-
58249095085
-
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
-
10.1038/onc.2008.374 18836486
-
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK, Oncogene 2009 28 209 218 10.1038/onc.2008.374 18836486
-
(2009)
Oncogene
, vol.28
, pp. 209-218
-
-
Baba, T.1
Convery, P.A.2
Matsumura, N.3
Whitaker, R.S.4
Kondoh, E.5
Perry, T.6
Huang, Z.7
Bentley, R.C.8
Mori, S.9
Fujii, S.10
Marks, J.R.11
Berchuck, A.12
Murphy, S.K.13
-
31
-
-
79961119901
-
Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
-
10.1016/j.yexmp.2011.06.005 21787767
-
Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome. Luo L, Zeng J, Liang B, Zhao Z, Sun L, Cao D, Yang J, Shen K, Exp Mol Pathol 2011 91 596 602 10.1016/j.yexmp.2011.06.005 21787767
-
(2011)
Exp Mol Pathol
, vol.91
, pp. 596-602
-
-
Luo, L.1
Zeng, J.2
Liang, B.3
Zhao, Z.4
Sun, L.5
Cao, D.6
Yang, J.7
Shen, K.8
-
32
-
-
77952240931
-
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
-
10.1038/onc.2010.35 20190812
-
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Gao MQ, Choi YP, Kang S, Youn JH, Cho NH, Oncogene 2010 29 2672 2680 10.1038/onc.2010.35 20190812
-
(2010)
Oncogene
, vol.29
, pp. 2672-2680
-
-
Gao, M.Q.1
Choi, Y.P.2
Kang, S.3
Youn, J.H.4
Cho, N.H.5
-
33
-
-
77956574908
-
More than markers: Biological significance of cancer stem cell-defining molecules
-
10.1158/1535-7163.MCT-10-0530 20716638
-
More than markers: biological significance of cancer stem cell-defining molecules. Keysar SB, Jimeno A, Mol Cancer Ther 2010 9 2450 2457 10.1158/1535-7163.MCT-10-0530 20716638
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 2450-2457
-
-
Keysar, S.B.1
Jimeno, A.2
-
34
-
-
74749089142
-
The role of cancer stem cells and the side population in epithelial ovarian cancer
-
19924647
-
The role of cancer stem cells and the side population in epithelial ovarian cancer. Fong MY, Kakar SS, Histol Histopathol 2010 25 113 120 19924647
-
(2010)
Histol Histopathol
, vol.25
, pp. 113-120
-
-
Fong, M.Y.1
Kakar, S.S.2
-
35
-
-
81255205360
-
Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis
-
10.1016/j.ccr.2011.10.014 22094257
-
Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Darido C, Georgy SR, Wilanowski T, Dworkin S, Auden A, Zhao Q, Rank G, Srivastava S, Finlay MJ, Papenfuss AT, Pandolfi PP, Pearson RB, Jane SM, Cancer Cell 2011 20 635 648 10.1016/j.ccr.2011.10.014 22094257
-
(2011)
Cancer Cell
, vol.20
, pp. 635-648
-
-
Darido, C.1
Georgy, S.R.2
Wilanowski, T.3
Dworkin, S.4
Auden, A.5
Zhao, Q.6
Rank, G.7
Srivastava, S.8
Finlay, M.J.9
Papenfuss, A.T.10
Pandolfi, P.P.11
Pearson, R.B.12
Jane, S.M.13
-
36
-
-
78650500590
-
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
-
10.1073/pnas.1015541107 21078976
-
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, Fabbri M, Sumani KM, Alder H, Amadori D, Patel T, Nuovo GJ, Fishel R, Croce CM, Proc Natl Acad Sci U S A 2010 107 21098 21103 10.1073/pnas.1015541107 21078976
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 21098-21103
-
-
Valeri, N.1
Gasparini, P.2
Braconi, C.3
Paone, A.4
Lovat, F.5
Fabbri, M.6
Sumani, K.M.7
Alder, H.8
Amadori, D.9
Patel, T.10
Nuovo, G.J.11
Fishel, R.12
Croce, C.M.13
-
37
-
-
84863510908
-
Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis
-
22318717
-
Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, Hung YC, Lin TY, Yeh S, Chang C, Hepatology 2012 56 176 185 22318717
-
(2012)
Hepatology
, vol.56
, pp. 176-185
-
-
Ma, W.L.1
Hsu, C.L.2
Yeh, C.C.3
Wu, M.H.4
Huang, C.K.5
Jeng, L.B.6
Hung, Y.C.7
Lin, T.Y.8
Yeh, S.9
Chang, C.10
-
38
-
-
84874299107
-
New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs non-stem/progenitor cells
-
22831834
-
New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells. Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, Yamashita S, Liang L, Tian J, Li L, Jiang Q, Huang CK, Niu Y, Yeh S, Chang C, J Mol Cell Biol 2012 5 14 26 22831834
-
(2012)
J Mol Cell Biol
, vol.5
, pp. 14-26
-
-
Lee, S.O.1
Ma, Z.2
Yeh, C.R.3
Luo, J.4
Lin, T.H.5
Lai, K.P.6
Yamashita, S.7
Liang, L.8
Tian, J.9
Li, L.10
Jiang, Q.11
Huang, C.K.12
Niu, Y.13
Yeh, S.14
Chang, C.15
-
39
-
-
33644838275
-
Disaggregation and invasion of ovarian carcinoma ascites spheroids
-
DOI 10.1186/1479-5876-4-6
-
Disaggregation and invasion of ovarian carcinoma ascites spheroids. Burleson KM, Boente MP, Pambuccian SE, Skubitz AP, J Transl Med 2006 4 6 10.1186/1479-5876-4-6 16433903 (Pubitemid 43362104)
-
(2006)
Journal of Translational Medicine
, vol.4
, pp. 6
-
-
Burleson, K.M.1
Boente, M.P.2
Pambuccian, S.E.3
Skubitz, A.P.N.4
-
40
-
-
78650756162
-
Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3
-
21109969
-
Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3. Guo R, Wu Q, Liu F, Wang Y, Oncol Rep 2011 25 141 146 21109969
-
(2011)
Oncol Rep
, vol.25
, pp. 141-146
-
-
Guo, R.1
Wu, Q.2
Liu, F.3
Wang, Y.4
-
41
-
-
80255137100
-
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
-
10.1002/ijc.25967 21480217
-
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W, Int J Cancer 2012 130 29 39 10.1002/ijc.25967 21480217
-
(2012)
Int J Cancer
, vol.130
, pp. 29-39
-
-
Kryczek, I.1
Liu, S.2
Roh, M.3
Vatan, L.4
Szeliga, W.5
Wei, S.6
Banerjee, M.7
Mao, Y.8
Kotarski, J.9
Wicha, M.S.10
Liu, R.11
Zou, W.12
-
42
-
-
84861466680
-
MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
-
10.1186/1755-8794-5-18 22643117
-
MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line. Nam EJ, Lee M, Yim GW, Kim JH, Kim S, Kim SW, Kim YT, BMC Med Genomics 2012 5 18 10.1186/1755-8794-5-18 22643117
-
(2012)
BMC Med Genomics
, vol.5
, pp. 18
-
-
Nam, E.J.1
Lee, M.2
Yim, G.W.3
Kim, J.H.4
Kim, S.5
Kim, S.W.6
Kim, Y.T.7
-
43
-
-
73349125059
-
CD133 expression defines a tumor initiating cell population in primary human ovarian cancer
-
19816957
-
CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R, Stem Cells 2009 27 2875 2883 19816957
-
(2009)
Stem Cells
, vol.27
, pp. 2875-2883
-
-
Curley, M.D.1
Therrien, V.A.2
Cummings, C.L.3
Sergent, P.A.4
Koulouris, C.R.5
Friel, A.M.6
Roberts, D.J.7
Seiden, M.V.8
Scadden, D.T.9
Rueda, B.R.10
Foster, R.11
-
44
-
-
77957067666
-
Identification and characterization of cancer stem cells in ovarian yolk sac tumors
-
10.1111/j.1349-7006.2010.01672.x 20804503
-
Identification and characterization of cancer stem cells in ovarian yolk sac tumors. Suzuki S, Terauchi M, Umezu T, Kajiyama H, Shibata K, Nawa A, Kikkawa F, Cancer Sci 2010 101 2179 2185 10.1111/j.1349-7006.2010.01672.x 20804503
-
(2010)
Cancer Sci
, vol.101
, pp. 2179-2185
-
-
Suzuki, S.1
Terauchi, M.2
Umezu, T.3
Kajiyama, H.4
Shibata, K.5
Nawa, A.6
Kikkawa, F.7
-
45
-
-
84865681797
-
MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells
-
22753745
-
MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells. Wong ST, Zhang XQ, Zhuang JT, Chan HL, Li CH, Leung GK, Anticancer Res 2012 32 2835 2841 22753745
-
(2012)
Anticancer Res
, vol.32
, pp. 2835-2841
-
-
Wong, S.T.1
Zhang, X.Q.2
Zhuang, J.T.3
Chan, H.L.4
Li, C.H.5
Leung, G.K.6
-
46
-
-
79956313718
-
Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer
-
10.1074/jbc.M110.216887 21471222
-
Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. Gong C, Yao Y, Wang Y, Liu B, Wu W, Chen J, Su F, Yao H, Song E, J Biol Chem 2011 286 19127 19137 10.1074/jbc.M110.216887 21471222
-
(2011)
J Biol Chem
, vol.286
, pp. 19127-19137
-
-
Gong, C.1
Yao, Y.2
Wang, Y.3
Liu, B.4
Wu, W.5
Chen, J.6
Su, F.7
Yao, H.8
Song, E.9
-
47
-
-
79961088478
-
MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN
-
10.1016/j.arcmed.2011.06.008 21820606
-
MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Wang ZX, Lu BB, Wang H, Cheng ZX, Yin YM, Arch Med Res 2011 42 281 290 10.1016/j.arcmed.2011.06.008 21820606
-
(2011)
Arch Med Res
, vol.42
, pp. 281-290
-
-
Wang, Z.X.1
Lu, B.B.2
Wang, H.3
Cheng, Z.X.4
Yin, Y.M.5
-
48
-
-
79954523687
-
MicroRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells
-
21468550
-
microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. Tao J, Lu Q, Wu D, Li P, Xu B, Qing W, Wang M, Zhang Z, Zhang W, Oncol Rep 2011 25 1721 1729 21468550
-
(2011)
Oncol Rep
, vol.25
, pp. 1721-1729
-
-
Tao, J.1
Lu, Q.2
Wu, D.3
Li, P.4
Xu, B.5
Qing, W.6
Wang, M.7
Zhang, Z.8
Zhang, W.9
-
49
-
-
84867492349
-
Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells
-
10.1016/j.jpedsurg.2012.05.013 23084187
-
Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells. Chen Y, Tsai YH, Fang Y, Tseng SH, J Pediatr Surg 2012 47 1797 1805 10.1016/j.jpedsurg.2012.05.013 23084187
-
(2012)
J Pediatr Surg
, vol.47
, pp. 1797-1805
-
-
Chen, Y.1
Tsai, Y.H.2
Fang, Y.3
Tseng, S.H.4
-
50
-
-
84866059004
-
Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression
-
10.3109/13880209.2012.665931 22957792
-
Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression. Li H, Hui L, Xu W, Shen H, Chen Q, Long L, Zhu X, Pharm Biol 2012 50 1233 1240 10.3109/13880209.2012.665931 22957792
-
(2012)
Pharm Biol
, vol.50
, pp. 1233-1240
-
-
Li, H.1
Hui, L.2
Xu, W.3
Shen, H.4
Chen, Q.5
Long, L.6
Zhu, X.7
-
51
-
-
84882565977
-
MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen
-
23275230
-
MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen. Bai H, Wei J, Deng C, Yang X, Wang C, Xu R, Int J Hematol 2012 97 223 231 23275230
-
(2012)
Int J Hematol
, vol.97
, pp. 223-231
-
-
Bai, H.1
Wei, J.2
Deng, C.3
Yang, X.4
Wang, C.5
Xu, R.6
-
52
-
-
33845671339
-
+ cancer stem cells in glioblastoma
-
DOI 10.1186/1476-4598-5-67
-
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS, Mol Cancer 2006 5 67 10.1186/1476-4598-5-67 17140455 (Pubitemid 44942887)
-
(2006)
Molecular Cancer
, vol.5
, pp. 67
-
-
Liu, G.1
Yuan, X.2
Zeng, Z.3
Tunici, P.4
Ng, H.5
Abdulkadir, I.R.6
Lu, L.7
Irvin, D.8
Black, K.L.9
Yu, J.S.10
-
53
-
-
77952893906
-
CD133 expression in chemo-resistant Ewing sarcoma cells
-
10.1186/1471-2407-10-116 20346143
-
CD133 expression in chemo-resistant Ewing sarcoma cells. Jiang X, Gwye Y, Russell D, Cao C, Douglas D, Hung L, Kovar H, Triche TJ, Lawlor ER, BMC Cancer 2010 10 116 10.1186/1471-2407-10-116 20346143
-
(2010)
BMC Cancer
, vol.10
, pp. 116
-
-
Jiang, X.1
Gwye, Y.2
Russell, D.3
Cao, C.4
Douglas, D.5
Hung, L.6
Kovar, H.7
Triche, T.J.8
Lawlor, E.R.9
-
54
-
-
70349479538
-
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
-
10.1073/pnas.0905653106 19805294
-
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabro E, Pastorino U, Sozzi G, Proc Natl Acad Sci U S A 2009 106 16281 16286 10.1073/pnas.0905653106 19805294
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 16281-16286
-
-
Bertolini, G.1
Roz, L.2
Perego, P.3
Tortoreto, M.4
Fontanella, E.5
Gatti, L.6
Pratesi, G.7
Fabbri, A.8
Andriani, F.9
Tinelli, S.10
Roz, E.11
Caserini, R.12
Lo Vullo, S.13
Camerini, T.14
Mariani, L.15
Delia, D.16
Calabro, E.17
Pastorino, U.18
Sozzi, G.19
-
55
-
-
84872005140
-
Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling
-
10.1158/0008-5472.CAN-12-1733 23135908
-
Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, Shen CN, Lu PJ, Hsiao M, Cancer Res 2013 73 406 416 10.1158/0008-5472.CAN-12-1733 23135908
-
(2013)
Cancer Res
, vol.73
, pp. 406-416
-
-
Liu, Y.P.1
Yang, C.J.2
Huang, M.S.3
Yeh, C.T.4
Wu, A.T.5
Lee, Y.C.6
Lai, T.C.7
Lee, C.H.8
Hsiao, Y.W.9
Lu, J.10
Shen, C.N.11
Lu, P.J.12
Hsiao, M.13
-
56
-
-
84858685991
-
Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation
-
10.1002/jcp.23041 21959795
-
Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation. Bodzin AS, Wei Z, Hurtt R, Gu T, Doria C, J Cell Physiol 2012 227 2947 2952 10.1002/jcp.23041 21959795
-
(2012)
J Cell Physiol
, vol.227
, pp. 2947-2952
-
-
Bodzin, A.S.1
Wei, Z.2
Hurtt, R.3
Gu, T.4
Doria, C.5
|